Pharma Two B
Broadcasting · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3 Prof. Haim Pekeris St, Rehovot, Centra...Phone Number
+972 89472672Website
www.pharma2b.comRevenue
$5.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Pharma Two B
Tubidy is an online platform that allows users to search, stream, and download a vast collection of music and videos for free. Known for its user-friendly interface, Tubidy provides high-quality audio and video downloads without the need for registration. The platform caters to a diverse audience by offering content across various genres and moods, making it suitable for different listening preferences. With its hassle-free experience and extensive library, Tubidy has become a popular choice for those seeking easy access to multimedia content.Explore more
Pharma Two B Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pharma Two B your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Pharma Two B has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Pharma Two B launches new products
Pharma Two B, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Pharma Two B is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Pharma Two B recently announced quarterly report
Click to see if Pharma Two B had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Pharma Two B has new funding data
Congratulate Masked Content for being promoted to Masked Content at Pharma Two B
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Pharma Two B is experiencing very low activity levels compared to other companies in the Media & Internet sector.
What does this means?
Pharma Two B is drawing exceptional interest within the Media & Internet industry, suggesting notable developments or strong market momentum, learn more about Pharma Two B.
Pharma Two B financials insights
Gather financial insights about Pharma Two B, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Series B
$8M
2017
Private Equity
$30M
Pharma Two B Tech Stack
A closer look at the technologies used by Pharma Two B
See more technologies
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
New Hire
Executive Move
Left Company
Executive Move
David Tierney, Chief Executive Officer, has left the organization.
New Hire
Executive Move
Pharma Two B News & Media
Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger
KIRYAT ONO, ISRAEL and EDISON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination product candidate for the treatment of Parkinson’s Disease (“PD”) and Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (“Hepion”), a clinical stage biopharmaceutical company that had been developing a treatment for non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and other chronic liver diPharma Two B and Hepion Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form F-4 Related to Proposed Merger
KIRYAT ONO, ISRAEL and EDISON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination product candidate for the treatment of Parkinson’s Disease (“PD”) and Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (“Hepion”), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and other chronic liver dPharma Two B Announces Plans to Go Public via Merger with Hepion Pharmaceuticals, Inc. and Concurrent $11.5 Million Private Placement
KIRYAT ONO, ISRAEL and EDISON, N.J., July 22, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and other chronic liver diseases, today announced it has entered into a definitive merger agreement (the “Merger Agreement”) with Pharma Two B Ltd., a late-clinical stage private Israeli company that is developing P2B001, an iPharma Two B to Present Additional Positive Results from P2B001 Phase 3 Trial at 2023 American Academy of Neurology Annual Meeting
REHOVOT, Israel, April 23, 2023 (GLOBE NEWSWIRE) -- Pharma Two B, a private, venture-backed, late-stage pharmaceutical company, today announced that additional results from the Phase 3 pivotal clinical trial evaluating P2B001, will be presented at the 2023 American Academy of Neurology (AAN) Annual Meeting, April 22-27 in Boston, MA. The data are being presented as an oral (Abstract 3733) and poster (Abstract 2396) presentation.
Read more news
Top Broadcasting Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pharma Two B
Sign Up For FreeTo access detailed company insights
Tubidy is an online platform that allows users to search, stream, and download a vast collection of music and videos for free. Known for its user-friendly interface, Tubidy provides high-quality audio and video downloads without the need for registration. The platform caters to a diverse audience by offering content across various genres and moods,... Read More
